Targeting Hyperlipidemia: Investigating the Regulatory Roles of NPC1L1 and SREBP-2 and the Therapeutic Potential of

Suresh Kumar Dev1, Rajnish Srivastava2, Aruna Sharma2

  • 1Venkateshwara Institute of Pharmacy, Sai Tirupati University, Udaipur, Rajasthan, India.

Abstract

Insights

Phytomedicines offer a natural approach to managing hyperlipidemia by inhibiting cholesterol absorption and synthesis. These plant-based compounds also enhance cholesterol excretion, providing an alternative to conventional drugs for cardiovascular health.

Area of Science:

  • Pharmacology and Phytomedicine
  • Cardiovascular Disease Research
  • Lipid Metabolism

Background:

  • Hypercholesterolemia, a prevalent form of dyslipidemia, significantly contributes to cardiovascular disease.
  • The global incidence of dyslipidemias has steadily increased over the last three decades.

Purpose of the Study:

  • To review the scientific evidence on the role of phytomedicine in managing hyperlipidemia.
  • To synthesize information on plant-based bioactives affecting cholesterol metabolism, focusing on mechanisms and efficacy.

Main Methods:

  • A comprehensive literature review was conducted using Google Scholar and PubMed.
  • Keywords included "Herbs, Medicinal plants, Bioactives, Dyslipidemia, Hyperlipidemia, lipid metabolism, NPC1L1, SREBP-2."
  • Studies published between 2000 and 2025, focusing on regulatory roles of NPC1L1 and SREBP-2, were included.

Main Results:

  • Plant-based bioactives modulate lipid levels through transcription factors like LXR, SREBP, PPARα, and PPARγ.
  • Key molecules in these pathways include NPC1L1, HMGCR, PCSK9, and CYP7A1, influencing cholesterol homeostasis.
  • Bioactives affect cholesterol uptake, esterification, synthesis, and excretion.

Conclusions:

  • Lipid-lowering agents are crucial for preventing atherosclerosis, coronary heart disease, and metabolic syndrome.
  • Herbal medicine presents a viable alternative or complementary approach to synthetic drugs for hyperlipidemia treatment.
  • Plant-derived compounds effectively inhibit intestinal cholesterol absorption, reduce hepatic cholesterol synthesis, and promote cholesterol excretion.

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Transducer Mechanism: Nuclear Receptors01:31

Transducer Mechanism: Nuclear Receptors

Nuclear receptors, or NRs, are unique transcription factors that regulate gene transcription and affect the cellular pathways involved in reproduction, development, or metabolism. Their ability to be stimulated by small lipophilic ligands and control vital cellular processes makes them ideal drug targets. Nearly 10-15% of currently prescribed drugs target these receptors.
About 48 different soluble family members of nuclear receptors are identified that can be divided into two main classes:
Regulation of Nuclear Protein Sorting01:45

Regulation of Nuclear Protein Sorting

Nuclear protein sorting regulates nucleus composition and gene expression, crucial for determining the fate of a eukaryotic cell. Hence, the entry and exit of molecules across the nuclear envelope is a tightly controlled process. Nuclear protein sorting can be inhibited by one of the following ways: 1) masking cargo signal sequences, 2) modifying the nuclear receptor's affinity for cargo, 3) controlling the nuclear pore size, 4) retaining the cargo during its transit to the cytosol or the...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...